← Back to Patent Explorer
US3981865A Expired / Lapsed US ⏱️ 0.0 years remaining

Bis-type penicillins and process for producing the same

Assignee: Toyama Chemical Co Ltd
•
Filing: 1975-06-11
•
Granted: 1976-09-21
•
Expires: 1995-06-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel bis-type penicillins containing a (thio)acylureido group in the molecule, which are valuable antibacterial compounds for use in mammals including a human being.

Inventors

  • 👤 Isamu Saikawa
  • 👤 Shuntaro Takano
  • 👤 Okuta Takashima
  • 👤 Kaishu Momonoi
  • 👤 Seietsu Kuroda
  • 👤 Miwako Komatsu
  • 👤 Takashi Yasuda
  • 👤 Kyoko Kasuya
  • 👤 Yutaka Kodama

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 04:41
CPC Classifications
C; C07; C07D; C07D499/00

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 115 words
A compound represented by the general formula (I), ##EQU13## wherein R is the radical derived from a conventional penicillin acylamido group represented by the formula ##EQU14## in which R 4 represents a substituted or unsubstituted alkyl, cycloalkyl, cycloalkenyl, cycloalkadienyl, aryl, aralkyl, aryloxy, alkylthioalkyl, or a heterocyclic group; and R 5 represents a hydrogen atom; R 4 and R 5 together with the common carbon atom may form a cycloalkyl, cycloalkenyl or cycloalkadienyl ring; R 1 represents a hydrogen atom, a conventional penicillin blocking group or a conventional penicillin saltforming cation R 2 represents a substituted or unsubstituted alkylene, alkenylene, cycloalkylene, arylene, alkylenediaryl group; X and Y are individually an oxygen atom or a sulfur atom.
Claim 2
Dependent Claim 115 words
A compound represented by the general formula (I), ##EQU13## wherein R is the radical derived from a conventional penicillin acylamido group represented by the formula ##EQU14## in which R 4 represents a substituted or unsubstituted alkyl, cycloalkyl, cycloalkenyl, cycloalkadienyl, aryl, aralkyl, aryloxy, alkylthioalkyl, or a heterocyclic group; and R 5 represents a hydrogen atom; R 4 and R 5 together with the common carbon atom may form a cycloalkyl, cycloalkenyl or cycloalkadienyl ring; R 1 represents a hydrogen atom, a conventional penicillin blocking group or a conventional penicillin saltforming cation R 2 represents a substituted or unsubstituted alkylene, alkenylene, cycloalkylene, arylene, alkylenediaryl group; X and Y are individually an oxygen atom or a sulfur atom.
Claim 3
Dependent Claim 40 words
A compound represented by the general formula (Ia), ##EQU15## wherein R 1 , Y and R 4 and R 5 are defined in claim 1 and R 6 represents a substituted or unsubstituted alkylene, alkenylene, cycloalkylene, arylene or alkylenediaryl group.
Claim 4
Dependent Claim 19 words
A compound according to claim 2, wherein R 6 is a substituted or unsubstituted alkylene, alkenylene or cycloalkylene group.
Claim 5
Dependent Claim 16 words
A compound according to claim 2, wherein R 6 is a substituted or unsubstituted arylene group.
Claim 6
Dependent Claim 13 words
A compound according to claim 2, wherein R 6 is an alkylenediaryl group.
Claim 7
Dependent Claim 13 words
A compound according to claim 1, wherein R 1 is a hydrogen atom.
Claim 8
Dependent Claim 47 words
A compound according to claim 1, wherein R 1 is selected from the group consisting of ester-forming groups capable of being removed by catalytic reduction, chemical reduction or hydrolysis under mild conditions and ester-forming groups capable of being easily removed owing to enzymes in a living body.
Claim 9
Dependent Claim 63 words
A compound selected from the group consisting of N,n'-1-methyl-1-propylmalonyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-succinyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-glutaryl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-adipoly-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-pimeloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-sebacoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-dodecanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-tridecanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-fumaroyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-1,4-cyclohexanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-sebacoyl-bis[6-(D(-)-α-ureido-hydroxyphenylacetamido penicillanic acid], N,n'-sebacoyl-bis[6-(1-ureidocyclohexylcarbonylamido) penicillanic acid], N,n'-terephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-isophthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-terephthaloyl-bis[6-(D(-)-α-thioureidophenylacetamido) penicillanic acid], N,n'-2-nitroterephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-2,5-dimethoxyterephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], and N,n'-2,6-naphthalenedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid].
Claim 10
Dependent Claim 63 words
A compound selected from the group consisting of N,n'-1-methyl-1-propylmalonyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-succinyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-glutaryl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-adipoly-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-pimeloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-sebacoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-dodecanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-tridecanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-fumaroyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-1,4-cyclohexanedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-sebacoyl-bis[6-(D(-)-α-ureido-hydroxyphenylacetamido penicillanic acid], N,n'-sebacoyl-bis[6-(1-ureidocyclohexylcarbonylamido) penicillanic acid], N,n'-terephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-isophthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-terephthaloyl-bis[6-(D(-)-α-thioureidophenylacetamido) penicillanic acid], N,n'-2-nitroterephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], N,n'-2,5-dimethoxyterephthaloyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid], and N,n'-2,6-naphthalenedioyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid].
Claim 11
Dependent Claim 5 words
The compound N,n'-4,4'-ethylenedibenzoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid].
Claim 12
Dependent Claim 5 words
The compound N,n'-4,4'-ethylenedibenzoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid].
Claim 13
Dependent Claim 15 words
A compound selected from the group consisting of dipivaloyloxymethyl N,N'-terephthaloyl-bis-[6-(D(-)-α-ureidophenylacetamido) penicillanate], and diphthalidyl N,N'-sebacoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanate].
Claim 14
Dependent Claim 15 words
A compound selected from the group consisting of dipivaloyloxymethyl N,N'-terephthaloyl-bis-[6-(D(-)-α-ureidophenylacetamido) penicillanate], and diphthalidyl N,N'-sebacoyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanate].
Claim 15
Dependent Claim 18 words
A compound according to claim 1, wherein R 1 is a cation capable of forming a non-toxic salt.
Claim 16
Dependent Claim 10 words
A non-toxic salt of a compound according to claim 8.
Claim 17
Dependent Claim 7 words
N,N'-succinyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid] or its non-toxic salt.
Claim 18
Dependent Claim 7 words
N,N'-succinyl-bis[6-(D(-)-α-ureidophenylacetamido) penicillanic acid] or its non-toxic salt.
Claim 19
Dependent Claim 12 words
A pharmaceutical composition containing an active ingredient a compound of claim 1.

References Cited (Backward Citations)

US3838152A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-09-21 1980-03-22 1980-09-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-09-21 1984-03-22 1984-09-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-09-21 1988-03-22 1988-09-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag